Transplant-associated thrombotic microangiopathy (TA-TMA) is a severe complication of
allogeneic hematopoietic cell transplantation (allo-HCT) with multisystem involvement …

Aims Post‐transplant thrombotic microangiopathy (TMA) is a rare and clinically challenging
finding in renal transplant biopsies. In addition to recurrent atypical haemolytic uraemic …

Thrombotic microangiopathy (TMA) is characterized by thrombocytopenia and
microangiopathic hemolytic anemia, results from acute and/or chronic endothelial cell injury …

Mutations in one or more genes encoding complement-regulatory proteins predispose to
atypical hemolytic uremic syndrome (aHUS) and its recurrence following kidney …

Hematopoietic stem cell transplantation (HSCT)-associated thrombotic microangiopathy (TA-
TMA) is a multifactorial complication. Complement dysregulation may play an important role …

Thrombotic microangiopathy (TMA) is one of the most devastating sequalae of kidney
transplantation. A number of published articles have covered either de novo or recurrent …

Background The identification of complement defects as major drivers of primary atypical
hemolytic uremic syndrome (HUS) has transformed the landscape of thrombotic …

Background: Analysis of the incidence, time to event, and risk factors for thrombotic
microangiopathy (TMA) after renal transplantation (RT), has not been reported in a national …

Thrombotic microangiopathy (TMA) encompasses various genetically-driven diseases. The
emergence of ultrafast genomic sequencing has recently opened up new avenues of …